Version: 1.0.640066 | Published: 9 Feb 2026 | Updated: 272 days ago
Documentation
Description:
CSF Olink Explore 3072 data measured for 328 participants as part of the complement biomarker study from the European Platform for Neurodegenerative Diseases (EPND). Measures include the 8 panels of Cardiometabolic, Cardiometabolic II, Inflammation, Inflammation II, Neurology, Neurology II, Oncology, and Oncology II. CSF samples were centrally measured at Sanofi. The complement biomarker study is a substudy of the EPND ATN study.
Coverage
Spatial:
US
Follow Up:
Unknown
Provenance
Temporal
Accrual Periodicity:
Static
Start Date:
01 January 2026
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
See dataset for details. Access data at: https://discover.alzheimersdata.org/catalogue/datasets/0719c789-4075-4f43-a883-2a8f8c1717dd
Access Service:
Delivery Lead Time:
Variable
Usage
Resource Creators:
Stephanie Vos;,;Marianna Rizzo;,;Pieter Jelle Visser
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
328
Count
01 January 2026